Congenital muscular dystrophy with merosin deficiency: 1H MR spectroscopy and diffusion-weighted MR imaging

Radiology

Volumn 235, Issue 1, 2005, Pages 190-196

  Leite, Claudia C ^a,b   Reed, Umbertina C ^a   Otaduy, Maria C G ^a   Lacerda, Maria T C ^a   Costa, Maria O R ^a   Ferreira, Lúcio G ^a   Carvalho, Mary S ^a   Resende, Maria B D ^a   Marie, Suely K N ^a   Cerri, Giovanni G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE; INOSITOL; MEROSIN; N ACETYLASPARTIC ACID; WATER;

ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MALE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTON NUCLEAR MAGNETIC RESONANCE; STATISTICAL ANALYSIS; WHITE MATTER;

CHILD; CHILD, PRESCHOOL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; HYDROGEN; LAMININ; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUSCULAR DYSTROPHIES; PROSPECTIVE STUDIES;

EID: 20144388522     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2351031963     Document Type: Article

References (45)

1. Fukuyama Y. Congenital muscular dystrophies: an update. J Child Neurol 1999; 14:28-30.
2. Tomé F. The saga of congenital muscular dystrophy. Neuropediatrics 1999; 30:55-65.
3. Muntoni F, Brockington M, Blake DJ, Torelli S, Brown SC. Defective glycosylation in muscular dystrophy. Lancet 2002; 360:1419-1421.
4. Muntoni F, Bertini E, Bonnemann C, et al. 98th ENMC International Workshop on Congenital Muscular Dystrophy (CMD), 7th Workshop of the International Consortium on CMD, 2nd Workshop of the MYO CLUSTER project GENRE. 26-28th October, 2001; Naarden, the Netherlands. Neuromuscul Disord 2002; 12:889-896.
5. Muntoni F, Guicheney P. 85th ENMC International Workshop on Congenital Muscular Dystrophy, 6th International CMD Workshop, 1st Workshop of the Myo-Cluster Project 'GENRE'. 27-28th October 2000; Naarden, the Netherlands. Neuromuscul Disord 2002; 12:69-78.
6. Pegoraro E, Marks H, Garcia CA, et al. Laminin alpha-2 muscular dystrophy: genotype/phenotype studies of 22 patients. Neurology 1998; 51:101-110.
7. Farina L, Morandi L, Milanesi I, et al. Congenital muscular dystrophy with merosin deficiency: MR findings in five patients. Neuroradiology 1998; 40:807-811.
8. Gilhuis HJ, ten Donkelaar HJ, Tanke RB, et al. Nonmuscular involvement in merosin-negative congenital muscular dystrophy. Pediatr Neurol 2002; 26:30-36.
9. Lamer S, Carlier RY, Pinard JM, et al. Congenital muscular dystrophy: use of brain MR imaging findings to predict merosin deficiency. Radiology 1998; 206:811-816.
10. Haase A, Frahm J, Hanicke W, Matthaei D. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985; 30:341-344.
11. van den Boogaart A, van Ormondt D, Pijnappel WWF, de Beer R, Ala-Korpela M. Removal of the water resonance from 1H magnetic resonance spectra. In: McWhirter JG, ed. Mathematics in signal processing III. Oxford, England: Clarendon, 1994; 175-195.
12. Vanhamme L, van den Boogaart A, van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129:35-43.
13. Pijnappel WW, van den Boogaart A, de Beer R, van Ormondt D. 5VD-based quantification of magnetic resonance signals. J Magn Reson 1992; 97:122-134.
14. Stejskal EO, Tanner JE. Spin diffusion measurements: spin-echoes in the presence of a time-dependent field gradient. J Chem Phys 1965; 42:288-292.
15. Burdette JH, Elster AD, Ricci PE. Calculation of apparent diffusion coefficients (ADCs) in brain using two-point and six-point methods. J Comput Assist Tomogr 1998; 22:792-794.
16. Tomé FM, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III 1994; 317:351-357.
17. Caro PA, Scavina M, Hoffman E, Pegoraro E, Marks HG. MR imaging findings in children with merosin-deficient congenital muscular dystrophy. AJNR Am J Neuroradiol 1999; 20:324-326.
18. Reed UC, Marie SK, Vainzof M, et al. Congenital muscular dystrophy with cerebral white matter hypodensity: correlation of clinical features and merosin deficiency. Brain Dev 1996; 18:53-58.
19. van der Knaap MS, Smit LM, Barth PG, et al. Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 1997; 42:50-59.
20. Philpot J, Cowan F, Pennock J, et al. Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging. Neuromuscul Disord 1999; 9:81-85.
21. Herrmann R, Straub V, Meyer K, Kahn T, Wagner M, Voit T. Congenital muscular dystrophy with laminin alpha 2 chain deficiency: identification of a new intermediate phenotype and correlation of clinical findings to muscle immunohistochemistry. Eur J Pediatr 1996; 155:968-976.
22. Barkovich AJ. Neuroimaging manifestations and classification of congenital muscular dystrophies. AJNR Am J Neuroradiol 1998; 19:1389-1396.
23. Taratuto AL, Lubieniecki F, Diaz D, et al. Merosin-deficiency congenital muscular dystrophy associated with abnormal cerebral cortical gyration: an autopsy study. Neuromuscul Disord 1999; 9:86-94.
24. Tsao CY, Mendell JR, Rusin J, Luquette M. Congenital muscular dystrophy with complete laminin-alpha2-deficiency, cortical dysplasia, and cerebral white-matter changes in children. J Child Neurol 1998; 13:253-256.
25. Sunada Y, Edgar TS, Lotz BP, Rust RS, Campbell KP. Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 1995; 45:2084-2089.
26. Pini A, Merlini L, Tomé FM, Chevallay M, Gobbi G. Merosin-negative congenital muscular dystrophy, occipital epilepsy with periodic spasms and focal cortical dysplasia: report of three Italian cases in two families. Brain Dev 1996; 18:316-322.
27. Grodd W, Krägeloh-Mann I, Petersen D, Trefz FK, Harzer K. In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 1990; 336:437-438.
28. Austin SJ, Connelly DA, Gadian DG, Benton JS, Brett EM. Localized 1H NMR spectroscopy in Canavan disease: a report of two cases. Magn Reson Med 1991; 19:439-445.
29. Brockmann K, Dechent P, Meins M, et al. Cerebral proton spectroscopy in infantile Alexander disease. J Neurol 2003; 250:300-306.
30. Grodd W, Krägeloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991; 181:173-181.
31. Wang ZJ, Zimmerman RA. Proton MR spectroscopy of pediatric brain metabolic disorders. Neuroimaging Clin N Am 1998; 8:781-807.
32. van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001; 22:541-552.
33. van der Knaap MS, Barth PG, Gabreëls FJ, et al. A new leukoencephalopathy with vanishing white matter. Neurology 1997; 48:845-855.
34. Rosemberg S, Leite CC, Arita FN, Kliemann SE, Lacerda MT. Leukoencephalopathy with vanishing white matter: report of four cases from three unrelated Brazilian families. Brain Dev 2002; 24:250-256.
35. Takanashi J, Sugita K, Osaka H, et al. Proton MR spectroscopy in Pelizaeus-Merzbacher disease. AJNR Am J Neuroradiol 1997; 18:533-535.
36. Eichler FS, Itoh R, Barker PB, et al. Proton MR spectroscopy and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radioiogy 2002; 225:245-252.
37. Sener RN. Metachromatic leukodystrophy: diffusion MR imaging and proton MR spectroscopy. Acta Radiol 2003; 44:440-443.
38. Danielsen ER, Ross B. The clinical significance of metabolites. In: Danielsen ER, Ross B. Magnetic resonance spectroscopy diagnosis of neurological diseases. New York, NY: Dekker, 1999; 23-43.
39. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000; 217:331-345.
40. Phillips MD, Zimmerman RA. Diffusion imaging in pediatric hypoxic-ischemic injury. Neuroimaging Clin N Am 1999; 9:41-52.
41. Nomura Y, Sakuma H, Takeda K, et al. Diffusional anisotrophy of the human brain assessed with diffusion-weighted MR: relation with normal brain development and aging. AJNR Am J Neuroradiol 1994; 15:231-238.
42. Engelbrecht V, Scherer A, Rassek M, Witsack HJ, Mödder U. Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. Radiology 2002; 222:410-418.
43. Schaefer PW, Buonnano FS, Gonzalez RG, Schwann LH. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997; 28:1082-1085.
44. Villanova M, Malandrini A, Sabatelli P, et al. Localization of laminin alpha 2 chain in normal human central nervous system: an immunofluorescence and ultrastructural study. Acta Neuropathol (Berl) 1997; 94:567-71.
45. Villanova M, Malandrini A, Toti P, et al. Localization of merosin in the normal human brain: implications for congenital muscular dystrophy with merosin deficiency. J Submicrosc Cytol Pathol 1996; 28:1-4.